0001831283-23-000054.txt : 20230331
0001831283-23-000054.hdr.sgml : 20230331
20230331162139
ACCESSION NUMBER: 0001831283-23-000054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230329
FILED AS OF DATE: 20230331
DATE AS OF CHANGE: 20230331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jahn Brianne
CENTRAL INDEX KEY: 0001885012
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40947
FILM NUMBER: 23788068
MAIL ADDRESS:
STREET 1: C/O LIANBIO
STREET 2: 103 CARNEGIE CENTER DRIVE, SUITE 215
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LianBio
CENTRAL INDEX KEY: 0001831283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 486-2308
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
wf-form4_168029408142979.xml
FORM 4
X0407
4
2023-03-29
0
0001831283
LianBio
LIAN
0001885012
Jahn Brianne
C/O LIANBIO
103 CARNEGIE CENTER DRIVE, SUITE 309
PRINCETON
NJ
08540
0
1
0
0
Chief Business Officer
0
Ordinary Shares
2023-03-29
4
A
0
224005
0
A
224005
D
Represents restricted share units granted to the Reporting Person under the LianBio 2021 Equity Incentive Plan. Each restricted share unit represents the contingent right to receive one share of the Issuer's Ordinary Shares. 25% of the restricted share units shall vest on March 29, 2024; the remainder shall vest in 25% annual installments such that the restricted share units are fully vested on March 29, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date.
By: /s/ Angela Chen, Attorney-in-Fact
2023-03-31